Perineural Dexmedetomidine in Adductor Canal Block

• Status: Completed
• Trial end date: 2018-12-05
• Target enrollment: 0
• Participant gender: All

Summary

This study is designed to explore the effects of peri-neural dexmedetomidine on the duration and motor sparing potentials of adductor canal block in adult patients undergoing arthroscopic medical meniscectomy in the setting of multimodal analgesia. The investigators ultimate goal is to increase the postoperative analgesic time and to preserve quadriceps muscle strength to promote safe and early ambulation.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cairo University
• Treatments: Bupivacaine; Dexmedetomidine

Criteria

Inclusion Criteria:

• Adult patients of aged (18-45), ASA physical status I or II undergoing arthroscopic medial meniscectomy.

Exclusion Criteria:

• Body mass index greater than 35 kg/m2.

• Pregnancy.

• Unstable coronary artery disease, congestive heart failure, or arrhythmias.

• Baseline heart rate (HR) less than 60 beats/min or baseline systolic blood pressure less than 100 mmHg.

• Pre-existing neurological deficits or neuropathy.

• Significant psychiatric or cognitive conditions interfering with consent or assessment.

• Significant renal or hepatic impairment;

• Severe bronchopulmonary disease, including chronic obstructive pulmonary disease and obstructive sleep apnea.

• Known contraindications to peripheral nerve block, including local skin infections, bleeding diathesis, and coagulopathy.

• Allergies to local anesthetics, dexmedetomidine, or any component of multimodal analgesia.